Zepp Health Statistics
Total Valuation
Zepp Health has a market cap or net worth of $69.22 million. The enterprise value is $133.86 million.
| Market Cap | 69.22M |
| Enterprise Value | 133.86M |
Important Dates
The last earnings date was Tuesday, September 1, 2026, after market close.
| Earnings Date | Sep 1, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Zepp Health has 14.66 million shares outstanding. The number of shares has decreased by -1.04% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 14.66M |
| Shares Change (YoY) | -1.04% |
| Shares Change (QoQ) | -0.23% |
| Owned by Insiders (%) | 35.45% |
| Owned by Institutions (%) | 15.69% |
| Float | 6.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.26 |
| Forward PS | n/a |
| PB Ratio | 0.42 |
| P/TBV Ratio | 0.44 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.90, with a Debt / Equity ratio of 0.73.
| Current Ratio | 0.90 |
| Quick Ratio | 0.48 |
| Debt / Equity | 0.73 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.41 |
Financial Efficiency
Return on equity (ROE) is -21.23% and return on invested capital (ROIC) is -13.37%.
| Return on Equity (ROE) | -21.23% |
| Return on Assets (ROA) | -3.92% |
| Return on Invested Capital (ROIC) | -13.37% |
| Return on Capital Employed (ROCE) | -14.17% |
| Weighted Average Cost of Capital (WACC) | 7.57% |
| Revenue Per Employee | $361,764 |
| Profits Per Employee | -$57,090 |
| Employee Count | 763 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 2.38 |
Taxes
In the past 12 months, Zepp Health has paid $2.51 million in taxes.
| Income Tax | 2.51M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.16% in the last 52 weeks. The beta is 1.89, so Zepp Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.89 |
| 52-Week Price Change | -90.16% |
| 50-Day Moving Average | 5.05 |
| 200-Day Moving Average | 14.76 |
| Relative Strength Index (RSI) | 47.93 |
| Average Volume (20 Days) | 62,770 |
Short Selling Information
The latest short interest is 379,663, so 5.91% of the outstanding shares have been sold short.
| Short Interest | 379,663 |
| Short Previous Month | 469,053 |
| Short % of Shares Out | 5.91% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 10.16 |
Income Statement
In the last 12 months, Zepp Health had revenue of $276.03 million and -$43.56 million in losses. Loss per share was -$2.79.
| Revenue | 276.03M |
| Gross Profit | 106.50M |
| Operating Income | -34.75M |
| Pretax Income | -41.05M |
| Net Income | -43.56M |
| EBITDA | -30.46M |
| EBIT | -34.75M |
| Loss Per Share | -$2.79 |
Balance Sheet
The company has $69.66 million in cash and $134.31 million in debt, with a net cash position of -$64.64 million or -$4.41 per share.
| Cash & Cash Equivalents | 69.66M |
| Total Debt | 134.31M |
| Net Cash | -64.64M |
| Net Cash Per Share | -$4.41 |
| Equity (Book Value) | 184.97M |
| Book Value Per Share | 11.68 |
| Working Capital | -31.86M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | -516,000 |
| Depreciation & Amortization | 4.29M |
| Net Borrowing | n/a |
| Free Cash Flow | -26.21M |
| FCF Per Share | -$1.79 |
Margins
Gross margin is 38.58%, with operating and profit margins of -12.59% and -15.78%.
| Gross Margin | 38.58% |
| Operating Margin | -12.59% |
| Pretax Margin | -14.87% |
| Profit Margin | -15.78% |
| EBITDA Margin | -11.03% |
| EBIT Margin | -12.59% |
| FCF Margin | n/a |
Dividends & Yields
Zepp Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.04% |
| Shareholder Yield | 1.04% |
| Earnings Yield | -60.37% |
| FCF Yield | -36.32% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 16, 2024. It was a reverse split with a ratio of 1:4.
| Last Split Date | Sep 16, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
Zepp Health has an Altman Z-Score of 0.68 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.68 |
| Piotroski F-Score | 3 |